ArticleClinical drug investigation2025

Cost-Effectiveness Analysis of Nirsevimab for the Prevention of Respiratory Syncytial Virus among Italian Infants.

Chiara Bini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.